Scleroderma Research Foundation EIN 68-0087234

Scleroderma Research Foundation

EIN  68-0087234 Public charity (501(c)(3)) San Francisco, CA Founded 1987
Form 990 (PDF) Compare with another nonprofit →
Verified accurate 7/21/26 · see original filing: IRS
Is this your organization?
Claim this profile to manage it and share your story.
Claim
Provided by the organization

This section is blank until Scleroderma Research Foundation claims this page.

Know this organization? Claim it to add your story

Size
$10–100M
What they do
Fund research and raise awareness to find treatments and a cure for scleroderma.
Leadership
Gregory Gordon · Chief Medical Officer · $526K
Money in and out
$13.1M revenue, $10.3M expenses
Bottom line
91% program efficiency

Fund research and raise awareness to find treatments and a cure for scleroderma. For fiscal year 2025 it reported $13.1M in revenue, $10.3M in expenses, and $16.9M in net assets.Pt I

Where the money goes · FY2025
Total revenue
$13.1M
Pt VIII · Ln 12
Total expenses
$10.3M
Pt IX · Ln 25
Net assets
$16.9M
Pt X · Ln 32
Revenue less expenses (Pt I · Ln 19): $2.8M
Where spending went · Part IX cols B–D
Program services $0.91 Management & general $0.03 Fundraising $0.06
Program efficiency
91%
of spending reaches programs▲ +3% vs prior filing year
Operating runway
46.2mo
months of highly liquid reserves at operating expense rate▲ +9% vs prior filing year
Surplus margin
+21%
revenue over expenses, this year▲ +2% vs prior filing year

Summary of the Filing

Part I · fiscal year 2025 · Form 990
Revenue
$13.1M
FY2025▲ +8%
Expenses
$10.3M
FY2025▲ +7%
Total assets
$42.2M
FY2025▲ +28%
Total liabilities
$25.4M
FY2025▲ +34%
Total revenue
$13.1M
Pt VIII · Ln 12
Total expenses
$10.3M
Pt IX · Ln 25
Net assets
$16.9M
Pt X · Ln 32
Revenue less expensesPt I · Ln 19$2.8M
Total assetsPt X · Ln 16$42.2M
Program-expense ratioPt IX · col B91%
Voting members of governing bodyPt I · Ln 312
Independent voting membersPt I · Ln 412
Mission & Programs · Part III

Where the work happens

3 program services account for $9.4M of program spending, described in the organization's own filed words · FY2025.
01

CONQUEST is a global, perpetual, clinical trial platform developed by the SRF in coordination with partner biopharmaceutical companies to accelerate the clinical development of agents for scleroderma.

$4.4Mprogram expense
02

The mission of the Scleroderma Research Foundation (SRF) is to find, fund, and facilitate the most promising, highest-quality research to cure scleroderma. We recruit the best and the brightest researchers to understand the causes, discover treatments, and ultimately eradicate this disease .

$4.3Mprogram expense
03

Srf Education & Awareness Program

Many patients hear the word scleroderma for the first time when they are diagnosed. We strive to raise awareness and provide educational resources because lack of awareness about scleroderma often causes delays in treatment or misdiagnosis.

$639Kprogram expense

Run this program? Claim this org to tell your story

Identity & Classification

Form 990 Header · IRS Business Master File
Legal nameHdr · item CScleroderma Research Foundation
EINHdr · item D68-0087234
Principal addressHdr · item CSan Francisco, CA
WebsiteHdr · item Jwww.srfcure.org
Year of formationHdr · item L1987
State of legal domicileHdr · item MCA
Exempt statusHdr · item I501(c)(3) · active
NTEE classificationIRS BMFMedical Research (H46Z)
Ruling yearIRS BMFMar 1987

Governance & Policies

Part VI
Voting members of the governing bodyPt VI · Ln 1a12
Independent voting membersPt VI · Ln 1b12
Conflict-of-interest policyPt VI · Ln 12aYes
Whistleblower policyPt VI · Ln 13Yes
Document retention policyPt VI · Ln 14Yes
CEO/top-official compensation independently reviewedPt VI · Ln 15aYes
Family or business relationships among officers/directorsPt VI · Ln 2Yes

Officers, Directors & Key Employees

Part VII, Section A · reportable compensation
Chief Medical Officer
$526,440Pt VII · Sec A
Executive Dir.
$220,205Pt VII · Sec A
VP Communications
$179,263Pt VII · Sec A
Dir. Communication
$130,689Pt VII · Sec A
SR. Acct. Manager
$118,965Pt VII · Sec A
Dir. Philanthropy
$112,854Pt VII · Sec A
$0Pt VII · Sec A
Secretary
$0Pt VII · Sec A

Gregory Gordon’s $526K as Chief Medical Officer is at the 64th percentile of top reported officer pay among 127 $10–100M medical research nonprofits. Peer set: organizations in the same NTEE major field of work and revenue-size band, compared on each org’s own highest-paid officer/key-employee, from Form 990 Part VII / 990-PF Part VIII. Descriptive placement, not a verdict on whether the pay is appropriate.

Compensation history total reportable pay by year · 8 named individuals · Part VII

NameFY2025FY2024FY2023FY2022FY2021FY2020
Gregory Gordon$526,440$416,000
Joanne Gold$220,205$215,900$203,286$193,724$193,236$160,792
Gloria Blecha$179,263$171,600$129,705$104,973
Kate Ceredona$152,258$152,315
Hannah Young$130,689$130,007$110,376
Neha Pamboo$118,965
Anoushka Donnelley$112,854
Cori Traub$108,558

Total reportable compensation (Form 990 Part VII column D / Schedule J column E) by filing year, matched by name within this organization. The Schedule J base / bonus / deferred breakdown is not parsed into this dataset.

See Scleroderma Research Foundation executive salaries →

Are you one of these people? Claim this org to confirm your role

Statement of Revenue

Part VIII
Program service revenue$5.9M · 45%
Contributions & grants$5.7M · 44%
Investment income$1.6M · 12%
Program service revenue45%$5.9M
Contributions & grants44%$5.7M
Investment income12%$1.6M
Total revenueLn 12$13.1M

Statement of Functional Expenses

Part IX · allocated across program, management, and fundraising
Allocation · columns B–D
Program services $0.91 Management & general $0.03 Fundraising $0.06
Program services91%$9.4M
Management & general3%$350K
Fundraising6%$575K
Total functional expensesLn 25$10.3M

Balance Sheet

Part X · end of year
CashLn 1$21.3M
Total assetsLn 16$42.2M
Total liabilitiesLn 26$25.4M
Total net assetsLn 32$16.9M
Months of cash on handcomputed24.8

Financial Metrics

Form 990 · FY2025 · each ratio shown with the dollars behind it
Liquidity & Payout
Operating runway
Highly liquid reserves $37.1M · Operating expenses (Pt IX) $10.3M · Less non-cash grants $684K · Cash operating expenses/yr $9.6M
46.2 months
Where the money goes
Program services
Program services $9.4M · Total expenses $10.3M
91%
Management & General
Management & general $350K · Total expenses $10.3M
3%
Fundraising
Fundraising $575K · Total expenses $10.3M
6%
Cost to raise $1
Fundraising expense (3-yr avg) $554K · Solicited contributions (3-yr avg) $4.7M
$0.12 to raise $1 (3-yr avg)
Where the money comes from
Contribution dependence
Contributions & grants $5.7M · Total revenue $13.1M
44%
Government reliance
Government grants — · Total revenue $13.1M
Earned-income share
Program service revenue $5.9M · Total revenue $13.1M
45%
Investment reliance
Investment income $1.6M · Total revenue $13.1M
+12%
Program self-sufficiency
Program service revenue $5.9M · Total expenses $10.3M
57%
Growth & trend
Revenue growth (YoY)
This year $13.1M · Prior year $12.2M
+8%
Revenue CAGR
FY2020 $3.9M · FY2025 $13.1M
+27%
Net-asset trend (YoY)
End of year $16.9M · Beginning of year —
Beginning net assets not meaningfully positive — showing dollar change
Balance sheet
Surplus Margin
Revenue $13.1M · Expenses $10.3M
+21%
Liabilities-to-Assets
Total liabilities — · Total assets $42.2M
Net-asset ratio
Net assets $16.9M · Total assets $42.2M
40%
Marketable Investment Share
Publicly traded securities (Pt X, ln 11) $15.8M · Other securities (Pt X, ln 12) $0 · Total assets (Pt X, ln 16) $42.2M
37%
People & payroll
Highest Reported Total Compensation
Individual Gregory Gordon · Reported title Chief Medical Officer · Highest reported compensation $526K · Total expenses $10.3M
5%
Personnel share
Salaries, benefits & payroll (Pt IX 5-10) $1.7M · Total expenses $10.3M
16%
Peer comparison

Same NTEE category, revenue band, and state where available. Descriptive — not a grade.

MetricThis orgPeer medianPercentile
Program ratio 91%
Overhead ratio 3%
Fundraising cost ratio 10%
Revenue growth 8%

Straight from the Form 990 — descriptive, not an evaluation. A ratio is hidden when its base is zero or too small to be meaningful; the dollars are always shown.

Grants

Schedule I · received and paid
Grants received · FY2025
Total grants receivedfrom 2 funders$5K
Grants paid · 124 grants · $15.9M · 2020–2025
Regents of Univ of Ca-UcsfCA · FY2025$466,635
University of UtahUT · FY2025$365,618
Univ of Tx Health Science CtrFY2025$314,255
Johns Hopkins UniversityMD · FY2025$212,416
University of PittsburghPA · FY2025$176,500
NYU Grossman School MedicineFY2025$150,000
Childrens Hospital CorporationMA · FY2025$147,103
Trustees of Dartmouth CollegeNH · FY2025$132,338
Yale UniversityCT · FY2025$125,000
Regents Univ of CaliforniaCA · FY2025$114,950
Duke UniversityNC · FY2025$103,057
Northwestern UniversityIL · FY2025$78,587
See all 124 grants →

Similar Organizations

Closest in mission — by what they do
See all organizations like Scleroderma Research Foundation →

Compare

Search another nonprofit to view revenue, expenses, assets, key metrics, and leaders side by side

Filings & Schedule Manifest

Part IV
III · Programs I · Grants R · Related orgs G · Fundraising L · Interested persons A · Public support F · Foreign M · Noncash
FY2025 (Latest)$13.1M revenue · viewing · ⤓ 990 PDF
FY2024$12.2M revenue · ⤓ 990 PDF
FY2023$8.4M revenue · ⤓ 990 PDF
FY2022$5.9M revenue · ⤓ 990 PDF
FY2021$3.8M revenue · ⤓ 990 PDF
FY2020$3.9M revenue · ⤓ 990 PDF

Want to add your own materials alongside these filings? Claim this org

Sources

Every figure above is drawn from these filings
Form 990 e-file (XML) · FY2025IRS
Classification, formation year, addressIRS Business Master File
Names, privacy, and removal requests More

The names, titles, and compensation shown on this page are reproduced from IRS Form 990 filings, which are public records.

Philanthropy.org does not alter the content of those filings. All information appears exactly as reported by the filing organization for the tax year shown.

We publish only information contained in the public IRS filing — and less than the filing contains. Our profile pages do not display street addresses, telephone numbers, personal email addresses, or other personal contact information, even where the filing includes them.

Many people share the same name. A name shown on this page reflects only what one organization reported in one IRS filing for one tax year. It should not be interpreted as identifying any other individual with the same or a similar name.

If you are no longer affiliated with the organization, your name will generally stop appearing in future IRS filings once the organization no longer reports you. Pages for tax years in which you were reported remain published because those filings remain part of the public record.

Philanthropy.org does not alter or remove IRS filing records. Removing a page from this website would not remove the underlying IRS filing, which remains publicly available from the IRS and other publishers of the same information.

If you believe the IRS filing itself is inaccurate, corrections must be made by the filing organization or the IRS directly.

If you ARE the filing organization, claim this org and add context

Made it to the end? Claim this organization

All figures are derived from public IRS Form 990 filings and are presented without evaluation of any organization. philanthropy.org does not rate, score, or rank organizations, including the peer-cohort and compensation comparisons above.